The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s Wegovy in the first head-to-head study of the rival medicines. Zepbound won on ...

GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...

"I stopped training like a man and switched to the 3-2-8 method—and everything changed!" Edwards wrote in one post. "The 3-2-8 is a workout regime/method, and it's a way of structuring a weekly ...

Losing weight with PCOS is challenging, but not impossible. While you can't spot-reduce belly fat, losing overall body fat can help shrink your midsection and reduce health risks. There's no ...

While you can't target belly fat alone spot reduction isn't scientifically supported, regular cycling especially when combined with a healthy diet helps burn more calories than you consume ...